Computer Based Educational Module for the Reduction of Arthralgia Syndrome Associated With Endocrine Therapy for Breast Cancer
18 Years
N/A
Female
Breast Cancer, Arthralgia
Trial Information
Computer Based Educational Module for the Reduction of Arthralgia Syndrome Associated With Endocrine Therapy for Breast Cancer
Inclusion Criteria:
- Post-menopausal stage I-III breast cancer patients
- Starting or about to start aromatase inhibitor
- English speaking with ability to read, write and use a computer to watch and listen
to an educational module.
- Able to give informed consent
Exclusion Criteria:
- Aromatase inhibitor (AI) use for more than 6 months
- Metastatic breast cancer
- Non-English speaking, or unable to read, write or use a computer to watch and listen
to an educational module.
- Unable to give informed consent
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Prevention
Outcome Measure:
Feasibility
Outcome Description:
This study is designed as a pilot study to assess feasibility of this educational intervention in a small population of only 40 patients. Patients will be given the option to complete the module from home. The primary endpoint will be patient completion of the educational module and follow-up questionnaires.
Outcome Time Frame:
3 months
Safety Issue:
No
Principal Investigator
Victoria K Shanmugam, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Georgetown University Hospital
Authority:
United States: Institutional Review Board
Study ID:
2010-548
NCT ID:
NCT01351844
Start Date:
May 2011
Completion Date:
September 2012
Related Keywords:
- Breast Cancer
- Arthralgia
- Aromatase inhibitor
- Arthralgia Syndrome
- Exercise
- Arthralgia
- Breast Neoplasms
Name | Location |
|---|---|
| Georgetown University Hospital | Washington, District of Columbia 20007 |
